Effects of Panax species and their bioactive components on allergic airway diseases

• Published in: Journal of ginseng research Vol. 48; no. 4; pp. 354 - 365
• Main Authors: Dahee Shim, Yeeun Bak, Han-Gyu Choi, Seunghyun Lee, Sang Chul Park
• Format: Journal Article
• Language: Korean
• Published: 2024
• Subjects: Allergic asthma; Immune response; Allergic rhinitis; Panax ginseng; Ginsenoside
• ISSN: 1226-8453; 2093-4947

Panax species include Panax ginseng Meyer, Panax quinquefolium L., Panax notoginseng, Panax japonicum, Panax trifolium, and Panax pseudoginseng, which contain bioactive components (BCs) such as ginsenosides and polysaccharides. Recently, growing evidence has revealed the pharmacological effects of Panax species and their BCs on allergic airway diseases (AADs), including allergic asthma (AA) and allergic rhinitis (AR). AADs are characterized by damaged epithelium, sustained acquired immune responses with enforced Th2 responses, allergenspecific IgE production, and enhanced production of histamine and leukotrienes by activated mast cells and basophils. In this review, we summarize how Panax species and their BCs modulate acquired immune responses involving interactions between dendritic cells and T cells, reduce the pro-inflammatory responses of epithelial cells, and reduce allergenic responses from basophils and mast cells in vitro. In addition, we highlight the current understanding of the alleviative effects of Panax species and their BCs against AA and AR in vivo. Moreover, we discuss the unmet needs of research and considerations for the treatment of patients to provide basic scientific knowledge for the treatment of AADs using Panax species and their BCs.